My Story:
There is no story for this user right now.

Latest Activity

Filter by:
Reply: Article: Unseen cause of bias that risks compromis...
Bingo...... As I said earlier; The endpoint must make sense in the ability to...More
Posted by iride6606
BLA for Novel Cholesterol Drug Submitted to FDA
The biologics license application has been filed with the FDA for Evolocumab and should...More
Posted by iride6606
New cholesterol guideline outperforms ATP III
Great article; The controversial 2013 American Heart Association/American College of...More
Posted by iride6606
Huge Decreases in LDL Cholesterol With Alirocumab
New lipid management drug is getting great reviews; After 65 weeks of treatment, the...More
Posted by iride6606
Reply: Article: Unseen cause of bias that risks compromis...
It is done for me, your Ebola comment was the perfect ending. Bobby, I answered your...More
Posted by iride6606
New Lipid Guidelines Prove Superior
Under NCEP guidelines, 59% of patients with 50% or more stenosis of the left main...More
Posted by iride6606
Reply: Article: Unseen cause of bias that risks compromis...
Sorry Bobby, I understand what the problem is now. Also, please understand that I am not...More
Posted by iride6606